365 related articles for article (PubMed ID: 18060269)
1. [Hepatocellular carcinoma: impact of waiting list and pre-operative treatment strategies on survival of cadaveric liver transplantation in pre-MELD era in one center in Brazil].
Freitas AC; Parolin MB; Stadnik L; Coelho JC
Arq Gastroenterol; 2007; 44(3):189-94. PubMed ID: 18060269
[TBL] [Abstract][Full Text] [Related]
2. The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil.
Freitas AC; Itikawa WM; Kurogi AS; Stadnik LG; Parolin MB; Coelho JC
Arq Gastroenterol; 2010; 47(3):233-7. PubMed ID: 21140081
[TBL] [Abstract][Full Text] [Related]
3. COMPARATIVE STUDY ON LIVER TRANSPLANTATION WITH AND WITHOUT HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS: ANALYSIS OF MELD, WAITING TIME AND SURVIVAL.
Freitas AC; Shiguihara RS; Monteiro RT; Pazeto TL; Coelho JC
Arq Bras Cir Dig; 2016 Mar; 29(1):21-5. PubMed ID: 27120734
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of waitlisted patients for liver transplantation at a liver transplantation unit in the city of Ribeirão Preto, São Paulo, Brazil, especially considering Child and Model for End Stage Liver Disease (MELD) scores.
Teixeira AC; Souza FF; Sankarankutty AK; Martinelli AL; Castro E Silva O
Transplant Proc; 2007 Mar; 39(2):387-9. PubMed ID: 17362738
[TBL] [Abstract][Full Text] [Related]
5. Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting.
Perricone G; Duvoux C; Berenguer M; Cortesi PA; Vinaixa C; Facchetti R; Mazzarelli C; Rockenschaub SR; Martini S; Morelli C; Monico S; Volpes R; Pageaux GP; Fagiuoli S; Belli LS;
Liver Int; 2018 Dec; 38(12):2170-2177. PubMed ID: 29750389
[TBL] [Abstract][Full Text] [Related]
6. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
7. Surgery for Hepatocellular Carcinoma in Patients with Child-Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation.
Harimoto N; Yoshizumi T; Fujimoto Y; Motomura T; Mano Y; Toshima T; Itoh S; Harada N; Ikegami T; Uchiyama H; Soejima Y; Maehara Y
World J Surg; 2018 Aug; 42(8):2606-2616. PubMed ID: 29372372
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation in the MELD era: a single-center experience.
Sachdev M; Hernandez JL; Sharma P; Douglas DD; Byrne T; Harrison ME; Mulligan D; Moss A; Reddy K; Vargas HE; Rakela J; Balan V
Dig Dis Sci; 2006 Jun; 51(6):1070-8. PubMed ID: 16865573
[TBL] [Abstract][Full Text] [Related]
9. LIVER TRANSPLANTATION IN HEPATITIS DELTA: SOUTH AMERICA EXPERIENCE.
Lima DS; Murad Júnior AJ; Barreira MA; Fernandes GC; Coelho GR; Garcia JHP
Arq Gastroenterol; 2018; 55(1):14-17. PubMed ID: 29561969
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
[TBL] [Abstract][Full Text] [Related]
11. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
12. HEPATOCELLULAR CARCINOMA PATIENTS ARE ADVANTAGED IN THE CURRENT BRAZILIAN LIVER TRANSPLANT ALLOCATION SYSTEM. A COMPETING RISK ANALYSIS.
Rodríguez S; Fleck AM; Mucenic M; Marroni C; Brandão A
Arq Gastroenterol; 2020; 57(1):19-23. PubMed ID: 32294731
[TBL] [Abstract][Full Text] [Related]
13. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
Mun BS; Ahn HS; Ahn DS; Lee SO
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
[TBL] [Abstract][Full Text] [Related]
14. [Results of liver transplantation in patients with hepatocellular carcinoma].
Parolin MB; Coelho JC; Matias JE; Puccinelli V; Jarabiza R; Ioshii SO
Arq Gastroenterol; 2001; 38(4):216-20. PubMed ID: 12068530
[TBL] [Abstract][Full Text] [Related]
15. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
16. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation.
Santoyo J; Suarez MA; Fernandez-Aguilar JL; Perez Daga JA; Sanchez-Perez B; Ramirez C; Aranda JM; Rodríguez-Canete A; Gonzalez-Sanchez A
Transplant Proc; 2006 Oct; 38(8):2462-4. PubMed ID: 17097967
[TBL] [Abstract][Full Text] [Related]
17. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA
Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
[TBL] [Abstract][Full Text] [Related]
18. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.
Teh SH; Christein J; Donohue J; Que F; Kendrick M; Farnell M; Cha S; Kamath P; Kim R; Nagorney DM
J Gastrointest Surg; 2005 Dec; 9(9):1207-15; discussion 1215. PubMed ID: 16332475
[TBL] [Abstract][Full Text] [Related]
19. HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST.
Nacif LS; Paranagua-Vezozzo DC; Matsuda A; Alves VAF; Carrilho FJ; Farias AQ; D'Albuquerque LC; Andraus W
Arq Bras Cir Dig; 2018 Jun; 31(1):e1360. PubMed ID: 29947694
[TBL] [Abstract][Full Text] [Related]
20. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
